Image

Home-Based Monitoring in Parkinson's Disease

Home-Based Monitoring in Parkinson's Disease

Recruiting
50-110 years
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to learn about the usefulness of automated analysis of speech, physical activity measures tracked using wearable devices at home, and tremor detection measured using computer-vision analysis of smartphone video to detect impairments related to Parkinson's disease and improve prediction of one-year progression.

Participants will attend a short research visit at the University of Iowa. During this visit, they will make a video recording using a smartphone of them performing a fine motor task and audio recordings of pre-written text. They will be provided with an activity tracker and asked to wear it at home for four weeks. After four weeks, a video visit will be conducted and the speech and video tasks will be repeated.

Description

Two groups of participants will be recruited. Group 1 will be patients newly referred to the Movement Disorders clinic for evaluation of possible Parkinson's disease. Group 2 will be patients with a recent (within 6 months) diagnosis of Parkinson's disease.

Group 1 (Newly Referred) will attend a baseline visit where the following data will be collected:

  • Unified Parkinson's Disease Rating Scale (UPDRS). The motor assessment tasks will be recorded using an iPad.
  • Montreal Cognitive Assessment (MoCA).
  • Cognitive function assessment using NIH Toolbox.
  • Diagnosis made at the Movement Disorders Clinic (PD or not PD).
  • SF-20 quality of life assessment. (Short Form 20)
  • PDQ-39 quality-of-life assessment. (Parkinson's Disease Questionnaire 39)
  • Tongue and lip strength using the Iowa Oral Pressure Instrument.
  • Cognitive function assessment using NIH Toolbox.
  • Audio recordings of:
  • Diadochokinesis (DDK) assessment.
  • Vowel prolongation assessment.
  • Sentence Intelligibility Test.
  • Reading the Grandfather, Bamboo, and Rainbow passages.
  • Recording of conversational speech.

Participants will be provided with an activity tracker and a research team member will help install any required apps on the participant's phone, configure and connect the activity tracker, provide a basic overview of how the app and tracker work, and answer any additional questions the participant may have.

The participant will then wear the activity tracker at home for 4 weeks. Text messages reminders will be sent following days with non-wear (no recorded heart rate or steps for multiple hours throughout the day) as a reminder to increase wear time.

At 4 weeks, the participant will complete a video visit using Microsoft Teams/Zoom with a study team member and the study participant. During the video visit, a recording of three different fine-motor skill tasks used in the UPDRS will be made. During the call, the study team member will provide coaching and direct the participant to repeat the audio and UPDRS fine motor task assessment at home while recording the video visit. At the end of the video visit, research team member will also collect questions about the ease and willingness to use the activity tracker and video call for disease monitoring and any open-ended comments the participant wishes to provide. This concludes the participants involvement in the study.

Group 2 (Recently Diagnosed) will attend a baseline visit where the following data will be collected:

  • Unified Parkinson's Disease Rating Scale (UPDRS). The motor assessment tasks will be recorded using an iPad.
  • Montreal Cognitive Assessment (MoCA).
  • Cognitive function assessment using NIH Toolbox.
  • Diagnosis made at the Movement Disorders Clinic (PD or not PD).
  • SF-20 quality of life assessment.
  • PDQ-39 quality-of-life assessment.
  • Tongue and lip strength using the Iowa Oral Pressure Instrument.
  • Cognitive function assessment using NIH Toolbox.
  • Audio recordings of:
  • Diadochokinesis (DDK) assessment.
  • Vowel prolongation assessment.
  • Sentence Intelligibility Test.
  • Reading the Grandfather, Bamboo, and Rainbow passages.
  • Recording of conversational speech.

Participants will be provided with an activity tracker and a research team member will help install any required apps on the participant's phone, configure and connect the activity tracker, provide a basic overview of how the app and tracker work, and answer any additional questions the participant may have.

The participant will then wear the activity tracker at home for 4 weeks. Text messages reminders will be sent following days with non-wear (no recorded heart rate or steps for multiple hours throughout the day) as a reminder to increase wear time.

At 4 weeks, the participant will complete a video visit using Microsoft Teams/Zoom with a study team member and the study participant. During the video visit, a recording of three different fine-motor skill tasks used in the UPDRS will be made. During the call, the study team member will provide coaching and direct the participant to repeat the audio and UPDRS fine motor task assessment at home while recording the video visit. At the end of the video visit, research team member will also collect questions about the ease and willingness to use the activity tracker and video call for disease monitoring and any open-ended comments the participant wishes to provide.

At 11 months, the participant will be contacted to schedule a one-year research visit. Many patients return on 3-6 month intervals to the UIHC Movement Disorders Clinic and the research visit will ideally coordinate the participants routine visit for care.

At the one-year encounter, which will be an in-person research visit, the following data elements will be collected:

  • Unified Parkinson's Disease Rating Scale (UPDRS).
  • Montreal Cognitive Assessment (MoCA).
  • Cognitive function assessment using NIH Toolbox.
  • SF-20.
  • PDQ-39 quality-of-life assessment.

Additionally, the research team will solicit any open-ended feedback the participant wants to share with the study team about their experience being in the study.

Eligibility

Group 1: People newly referred with possible Parkinson's disease

Inclusion Criteria

  1. Newly referred to UIHC Movement Disorders Clinic

Exclusion Criteria

  1. Prior diagnosis of Parkinson's disease
  2. Confined to wheelchair or bed
  3. Non-English speaking
  4. Prisoner status
  5. Inability to provide own informed consent
  6. Phone unable to support the Fitbit app

Group 2: People with a recent diagnosis of Parkinson's disease

Inclusion Criteria

  1. Patient of UIHC Movement Disorders Clinic
  2. Diagnosed with Parkinson's disease

Exclusion Criteria

  1. First diagnosed > 6 months ago
  2. Confined to wheelchair or bed
  3. Non-English speaking
  4. Prisoner status
  5. Inability to provide own informed consent
  6. Phone unable to support the Fitbit app

Study details
    Parkinson Disease

NCT06573762

Jacob E. Simmering

21 April 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.